Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
CD19 CAR T-cells with concurrent ibrutinib for ibrutinib-refractory CLL
Jordan Gauthier
Cookie settings
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.